Jean-Pierre Morello

A Peptide Derived from a β2-Adrenergic Receptor Transmembrane Domain Inhibits Both Receptor Dimerization and Activation

Terence E. Hébert, Serge Moffett, Jean-Pierre Morello et al. · Journal of Biological Chemistry · 1996 · 768 citations · Full text

Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants

Jean-Pierre Morello, Ali Salahpour, André Laperrière et al. · Journal of Clinical Investigation · 2000 · 556 citations · Full text

V2 Vasopressin Receptor, Cellular Physiology, Molecular Pharmacology +19

Pharmacologic Chaperones as a Potential Treatment for X-Linked Nephrogenic Diabetes Insipidus

Virginie Bernier, Jean-Pierre Morello, Alexandro Zarruk et al. · Journal of the American Society of Nephrology · 2005 · 241 citations

Pharmacotherapy, Cellular Physiology, Mutant V2 Receptors +17

Association of Calnexin with Wild Type and Mutant AVPR2 that Cause Nephrogenic Diabetes Insipidus

Jean-Pierre Morello, Ali Salahpour, Ulla E. Petäjä‐Repo et al. · Biochemistry · 2001 · 108 citations

V2 Vasopressin Receptor, Genetics, Pathology +18

Identification of a Potent and Selective Synthetic Agonist at the CRTH2 Receptor

François G. Gervais, Jean-Pierre Morello, Christian Beaulieu et al. · Molecular Pharmacology · 2005 · 48 citations